News & Updates

Show Multimedia Only

Esaxerenone improves vascular function, peripheral arterial stiffness in IHA patients

24 Jun 2025

Patients with idiopathic hyperaldosteronism (IHA) treated with esaxerenone show improved vascular function and reduced peripheral arterial stiffness, reports a study.

Esaxerenone improves vascular function, peripheral arterial stiffness in IHA patients

24 Jun 2025

BMI and glycaemic status significantly affect CV risk in patients treated with anthracyclines

24 Jun 2025 by

A retrospective cohort study of >11,000 Hong Kong patients who initiated anthracycline-based chemotherapy found that both body-mass index (BMI) and glycaemic status significantly affect cardiovascular (CV) risks, with the highest risk observed in those with concurrent obesity and diabetes/prediabetes.

BMI and glycaemic status significantly affect CV risk in patients treated with anthracyclines

24 Jun 2025

Original New Drug Application Approvals by US FDA (16-31 May 2025)

23 Jun 2025

New drug applications approved by US FDA as of 16-31 May 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 May 2025)

23 Jun 2025

Is it safe to take abelacimab before a procedure?

20 Jun 2025

Patients with atrial fibrillation (AF) who have been treated with the long-acting factor XI inhibitor abelacimab may undergo invasive procedures, as shown by the low rates of bleeding in a recent study.

Is it safe to take abelacimab before a procedure?

20 Jun 2025

Lower KCCQ-12 scores predict death in outpatient HF care

19 Jun 2025

During outpatient heart failure (HF) care, patients with lower scores in the Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) are at greater risk of hospitalizations and mortality, suggests a study. Moreover, those with scores <25 appear to have the highest risk.

Lower KCCQ-12 scores predict death in outpatient HF care

19 Jun 2025

Abbreviated vs prolonged DAPT: Is shorter better for at-risk patients?

19 Jun 2025

One-month treatment with dual antiplatelet therapy (DAPT) results in similar adverse events and a reduction in total bleeding risk when compared with prolonged DAPT, a study has shown.

Abbreviated vs prolonged DAPT: Is shorter better for at-risk patients?

19 Jun 2025

Study ties energy drink intake to unhealthy lifestyle in young individuals

19 Jun 2025 by

A study presented at ESPGHAN 2025 reports that schoolchildren who consume energy drinks have unhealthier lifestyles and a different cardiovascular risk profile than their counterparts who do not or rarely consume energy drinks.

Study ties energy drink intake to unhealthy lifestyle in young individuals

19 Jun 2025

Inclisiran superior to ezetimibe in LDL-C reduction in patients without ASCVD

18 Jun 2025

Treatment with inclisiran monotherapy demonstrates good tolerability and better reduction in low-density lipoprotein cholesterol (LDL-C) levels when compared with ezetimibe and placebo in patients without atherosclerotic cardiovascular disease (ASCVD), reports a study.

Inclisiran superior to ezetimibe in LDL-C reduction in patients without ASCVD

18 Jun 2025

Ferric carboxymaltose infusion offers little help in iron-deficient patients with heart failure

17 Jun 2025

Intravenous ferric carboxymaltose does not appear to be beneficial in terms of heart failure (HF) hospitalization and cardiovascular mortality in patients with HF and iron deficiency, according to a study.

Ferric carboxymaltose infusion offers little help in iron-deficient patients with heart failure

17 Jun 2025

SGLT2i extends survival in amyloidosis patients with or without HF

16 Jun 2025 by

Treatment with SGLT2 inhibitors can prolong the life of patients with amyloidosis with or without a diagnosis of heart failure (HF), a study has shown.

SGLT2i extends survival in amyloidosis patients with or without HF

16 Jun 2025

News & Updates

Showing Cardiology articles

Showing

Specialty:

Esaxerenone improves vascular function, peripheral arterial stiffness in IHA patients

Esaxerenone improves vascular function, peripheral arterial stiffness in IHA patients

BMI and glycaemic status significantly affect CV risk in patients treated with anthracyclines

BMI and glycaemic status significantly affect CV risk in patients treated with anthracyclines

Original New Drug Application Approvals by US FDA (16-31 May 2025)

Original New Drug Application Approvals by US FDA (16-31 May 2025)

Is it safe to take abelacimab before a procedure?

Is it safe to take abelacimab before a procedure?

Lower KCCQ-12 scores predict death in outpatient HF care

Lower KCCQ-12 scores predict death in outpatient HF care

Abbreviated vs prolonged DAPT: Is shorter better for at-risk patients?

Abbreviated vs prolonged DAPT: Is shorter better for at-risk patients?

Study ties energy drink intake to unhealthy lifestyle in young individuals

Study ties energy drink intake to unhealthy lifestyle in young individuals

Inclisiran superior to ezetimibe in LDL-C reduction in patients without ASCVD

Inclisiran superior to ezetimibe in LDL-C reduction in patients without ASCVD

Ferric carboxymaltose infusion offers little help in iron-deficient patients with heart failure

Ferric carboxymaltose infusion offers little help in iron-deficient patients with heart failure

SGLT2i extends survival in amyloidosis patients with or without HF

SGLT2i extends survival in amyloidosis patients with or without HF